Adebrelimab Plus Famitinib as Adjuvant Therapy in Non-pCR NSCLC

1. 20:00
   clinicaltrials.gov

   Adebrelimab Plus Famitinib as Adjuvant Therapy in Non-pCR NSCLC

Heat now 7·Peak in the comparable set 8 (Oct 23 03:00)·Change over 24h in the comparable set –·Participants now 1

Participants counted above, heat below. The trend compares only the participants observed in full throughout, so its set can be smaller than the heat figure itself. Move the pointer or click the chart for an hour's reading; the left and right arrow keys work too.